biologic < biological < biologically

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 109.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000008 (2010)	P. Roll [Allemagne] ; A. Rubbert-Roth [Allemagne] ; H.-P. Tony [Allemagne]	Tocilizumab
000012 (2005)	Norihiro Nishimoto [Japon]	Clinical studies in patients with Castleman’s disease, Crohn’s disease, and rheumatoid arthritis in Japan
000015 (2013)	Jörg Kaufmann [Allemagne] ; Eugen Feist [Allemagne] ; Anne-Eve Roske [Allemagne] ; Wolfgang A. Schmidt [Allemagne]	Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice
000030 (2010)	Katja Perdan-Pirkmajer [Slovénie] ; Sonja Praprotnik [Slovénie] ; Matija Tomši [Slovénie]	A case of refractory adult-onset Still’s disease successfully controlled with tocilizumab and a review of the literature
000031 (2005)	Shumpei Yokota [Japon] ; Takako Miyamae [Japon] ; Tomoyuki Imagawa [Japon] ; Shigeki Katakura [Japon] ; Rumiko Kurosawa [Japon] ; Masaaki Mori [Japon]	Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
000035 (2013)	T. Witte [Allemagne]	Methotrexat als Kombinationspartner bei TNF-Inhibitoren und Tocilizumab
000039 (2011)	Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon]	Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders
000063 (2010)		2.4. Rheumatoid arthritis ‐ non‐TNFα biological therapies
000066 (2013)	Kanae Tani [Japon] ; Risa Takayanagi [Japon] ; Haruko Yokoyama [Japon] ; Yasuhiko Yamada [Japon]	Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy
000074 (2010)	Keiichi Sumida [Japon] ; Yoshifumi Ubara [Japon] ; Junichi Hoshino [Japon] ; Tatsuya Suwabe [Japon] ; Rikako Hiramatsu [Japon] ; Eiko Hasegawa [Japon] ; Noriko Hayami [Japon] ; Masayuki Yamanouchi [Japon] ; Naoki Sawa [Japon] ; Fumi Takemoto [Japon] ; Kenmei Takaichi [Japon]	Etanercept-refractory adult-onset Still’s disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab
000075 (2011)	J. D. Alves [Portugal] ; A. Marinho [Portugal] ; M. J. Serra [Portugal]	Tocilizumab: is there life beyond anti‐TNF blockade?
000085 (2011)	Hiroki Wakabayashi [Japon] ; Akihiro Sudo [Japon] ; Yosuke Nishioka [Japon] ; Masahiro Hasegawa [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon]	Repeat etanercept administration restores clinical response of patients with rheumatoid arthritis
000087 (2011)	K. Krüger [Allemagne] ; B. Hellmich [Allemagne] ; A. Rubbert-Roth [Allemagne] ; U. Müller-Ladner [Allemagne] ; A. Kielhorn [Allemagne]	Ist der Vergleich verschiedener Studien zur Wirksamkeit von Biologika bei Patienten mit rheumatoider Arthritis möglich?
000100 (2012)	K. Tenbrock [Allemagne]	Therapie der juvenilen idiopathischen Arthritis (JIA)
000102 (2011)	Masahiko Suzuki [Japon] ; Keiichiro Nishida [Japon] ; Satoshi Soen [Japon] ; Hiromi Oda [Japon] ; Hiroshi Inoue [Japon] ; Atsushi Kaneko [Japon] ; Kenji Takagishi [Japon] ; Takaaki Tanaka [Japon] ; Tsukasa Matsubara [Japon] ; Naoto Mitsugi [Japon] ; Yuichi Mochida [Japon] ; Shigeki Momohara [Japon] ; Toshihito Mori [Japon] ; Toru Suguro [Japon]	Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: a report from the Committee on Arthritis of the Japanese Orthopaedic Association
000105 (2012)	M. Gallego-Galisteo ; A. Villa-Rubio ; E. Alegre-Del Rey [Espagne] ; E. Márquez-Fernández ; J. J. Ramos-Báez	Indirect comparison of biological treatments in refractory rheumatoid arthritis
000108 (2012)		2.4 Rheumatoid arthritis – non‐TNFα biological therapies
000135 (2012)	K. Krüger [Allemagne] ; J. Wollenhaupt [Allemagne] ; K. Albrecht [Allemagne] ; R. Alten [Allemagne] ; M. Backhaus [Allemagne] ; C. Baerwald [Allemagne] ; W. Bolten [Allemagne] ; J. Braun [Allemagne] ; H. Burkhardt [Allemagne] ; G. Burmester [Allemagne] ; M. Gaubitz [Allemagne] ; A. Gause [Allemagne] ; E. Gromnica-Ihle [Allemagne] ; H. Kellner [Allemagne] ; J. Kuipers [Allemagne] ; A. Krause [Allemagne] ; H.-M. Lorenz [Allemagne] ; B. Manger [Allemagne] ; H. Nü Lein [Allemagne] ; H.-G. Pott [Allemagne] ; A. Rubbert-Roth [Allemagne] ; M. Schneider [Allemagne] ; C. Specker [Allemagne] ; H. Schulze-Koops [Allemagne] ; H.-P. Tony [Allemagne] ; S. Wassenberg [Allemagne] ; U. Müller-Ladner [Allemagne]	S1-Leitlinie der DGRh zur sequenziellen medikamentösen Therapie der rheumatoiden Arthritis 2012
000174 (2012)	M. Gaubitz [Allemagne]	Biologika 2012
000190 (2008)	N. Leuchten [Allemagne] ; M. Aringer [Allemagne]	Rheumatoide Arthritis/chronische Polyarthritis heute
000193 (2012)	L. K. King ; A. Lee [Australie] ; A. Anandacoomarasamy [Australie]	Use of biological disease‐modifying anti‐rheumatic drugs in patients with concurrent rheumatic disease and hepatitis B

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "biological" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "biological" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    biological
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021